<DOC>
	<DOCNO>NCT00448669</DOCNO>
	<brief_summary>This study test whether take pill tenofovir emtricitabine ( two antiretroviral medicine ) safe sexually-active young adult Botswana without HIV infection whether reduce risk get HIV infection .</brief_summary>
	<brief_title>Botswana TDF/FTC Oral HIV Prophylaxis Trial</brief_title>
	<detailed_description>Twelve hundred nineteen healthy , sexually active woman men , 18-39 year old , without HIV infection enrol Francistown Gaborone , Botswana . They provide free male female condom , repeat individualized risk-reduction counseling , diagnosis treatment sexually transmitted disease , woman provide choice effective family plan method . In addition , volunteer randomize receive either Tenofovir emtricitabine ( single pill ) placebo pill take day . Volunteers see monthly least 12 month monitor side effect toxicity test HIV status . Persons become HIV infected trial receive ongoing supportive counseling , CD4 viral load monitoring , education HIV infection/disease , access HIV care include free antiretrovirals clinically indicate . Volunteer safety monitor local ethic committee , Centers Disease Control Institutional Review Board ( CDC IRB ) independent data safety monitoring board</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<mesh_term>Emtricitabine</mesh_term>
	<criteria>citizen Botswana 1839 year old sexually active HIV uninfected Hepatitis B C uninfected Calculated creatinine clearance &gt; = 60 mL/min hemoglobin &gt; = 8 gm/dL ALT AST &lt; = 2x ULN total bilirubin &lt; = 1.5 mg/dL total serum amylase &lt; = 1.5x ULN Serum phosphorus &gt; = 2.2 mg/dL willing use hormonal contraception ( female ) live within 1 hour travel study clinic pas comprehension test willing able give inform consent 1820 without parent/guardian consent history significant renal bone disease chronic illness require ongoing prescription medication pregnant breastfeeding planning move away site next year participate another HIV prevention vaccine safety trial clinical condition prior therapy , opinion study physician , would make volunteer unsuitable study unable comply dosing requirement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>HIV incidence</keyword>
	<keyword>HIV prevention</keyword>
	<keyword>Tenofovir</keyword>
	<keyword>Emtricitabine</keyword>
	<keyword>Botswana</keyword>
	<keyword>HIV seronegativity</keyword>
</DOC>